United Therapeutics' earnings underperform

United Therapeutics Corp. (NASDAQ:UTHR) fell $7.36 to $104.31 on Wednesday, losing about $320 million in market cap, after reporting 1Q18 earnings below expectations.

The biotech said 1Q18 non-GAAP

Read the full 279 word article

User Sign In